[go: up one dir, main page]

FI971037L - Multivesikulääristen liposomien valmistus aktiivisten aineiden vapauttamiseksi kontrolloidusti - Google Patents

Multivesikulääristen liposomien valmistus aktiivisten aineiden vapauttamiseksi kontrolloidusti Download PDF

Info

Publication number
FI971037L
FI971037L FI971037A FI971037A FI971037L FI 971037 L FI971037 L FI 971037L FI 971037 A FI971037 A FI 971037A FI 971037 A FI971037 A FI 971037A FI 971037 L FI971037 L FI 971037L
Authority
FI
Finland
Prior art keywords
preparation
active ingredients
controlled release
multivesicular liposomes
multivesicular
Prior art date
Application number
FI971037A
Other languages
English (en)
Swedish (sv)
Other versions
FI119621B (fi
FI971037A0 (fi
Inventor
Mantripragada B Sankaram
Sinil Kim
Original Assignee
Depotech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Depotech Corp filed Critical Depotech Corp
Publication of FI971037A0 publication Critical patent/FI971037A0/fi
Publication of FI971037L publication Critical patent/FI971037L/fi
Application granted granted Critical
Publication of FI119621B publication Critical patent/FI119621B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
FI971037A 1994-09-13 1997-03-12 Multivesikulääristen liposomien valmistus aktiivisten aineiden vapauttamiseksi kontrolloidusti FI119621B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US30515894 1994-09-13
US08/305,158 US5993850A (en) 1994-09-13 1994-09-13 Preparation of multivesicular liposomes for controlled release of encapsulated biologically active substances
PCT/US1995/011609 WO1996008235A1 (en) 1994-09-13 1995-09-13 Preparation of multivesicular liposomes for controlled release of active agents
US9511609 1995-09-13

Publications (3)

Publication Number Publication Date
FI971037A0 FI971037A0 (fi) 1997-03-12
FI971037L true FI971037L (fi) 1997-05-12
FI119621B FI119621B (fi) 2009-01-30

Family

ID=23179585

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971037A FI119621B (fi) 1994-09-13 1997-03-12 Multivesikulääristen liposomien valmistus aktiivisten aineiden vapauttamiseksi kontrolloidusti

Country Status (14)

Country Link
US (1) US5993850A (fi)
EP (1) EP0781123B1 (fi)
JP (1) JP3026271B2 (fi)
KR (1) KR100387561B1 (fi)
CN (1) CN1096850C (fi)
AU (1) AU697484B2 (fi)
BR (1) BR9508913A (fi)
CA (1) CA2199004C (fi)
DE (1) DE69535297T2 (fi)
FI (1) FI119621B (fi)
MX (1) MX9701856A (fi)
NO (1) NO323581B1 (fi)
NZ (2) NZ292830A (fi)
WO (1) WO1996008235A1 (fi)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6558952B1 (en) * 1992-12-14 2003-05-06 Waratah Pharmaceuticals, Inc. Treatment for diabetes
US5931809A (en) * 1995-07-14 1999-08-03 Depotech Corporation Epidural administration of therapeutic compounds with sustained rate of release
US5997899A (en) * 1996-10-01 1999-12-07 Skyepharma Inc. Method for producing liposomes with increased percent of compound encapsulated
KR19980067138A (ko) * 1997-01-31 1998-10-15 박원훈 유전자 또는 생물학적 활성 약물을 세포내로 효과적으로 전달하는 지방 유제 및 그것의 제조방법
US5891467A (en) * 1997-01-31 1999-04-06 Depotech Corporation Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
US6106858A (en) * 1997-09-08 2000-08-22 Skyepharma, Inc. Modulation of drug loading in multivescular liposomes
US6306432B1 (en) * 1997-09-08 2001-10-23 Chiron Corporation High and low load formulations of IGF-I in multivesicular liposomes
EP2308470A1 (en) 1997-09-18 2011-04-13 Pacira Pharmaceuticals, Inc. Sustained-release liposomal anesthetic compositions
NZ504188A (en) * 1997-11-14 2001-10-26 Skyepharma Inc Emulsification process for preparing multivesicular liposomes
EP1098610B1 (en) * 1998-07-17 2009-04-15 Pacira Pharmaceuticals, Inc. Biodegradable compositions for the controlled release of encapsulated substances
US20040037818A1 (en) * 1998-07-30 2004-02-26 Brand Stephen J. Treatment for diabetes
IL141095A0 (en) 1998-08-19 2002-02-10 Rtp Pharma Inc Injectable aqueous dispersions of propofol
US20030059440A1 (en) * 1998-09-01 2003-03-27 Tim Clarot Composition and method for moisturizing nasal tissue
US6740643B2 (en) * 1999-01-21 2004-05-25 Mirus Corporation Compositions and methods for drug delivery using amphiphile binding molecules
CA2365847A1 (en) * 1999-04-06 2000-10-12 Gregg M. Duthaler Methods for producing droplets for use in capsule-based electrophoretic displays
AUPQ259399A0 (en) 1999-09-01 1999-09-23 Lustre Investments Pte Ltd Therapeutic agents
US6812217B2 (en) 2000-12-04 2004-11-02 Medtronic, Inc. Medical device and methods of use
US6897196B1 (en) * 2001-02-07 2005-05-24 The Regents Of The University Of California pH sensitive lipids based on ortho ester linkers, composition and method
DE10109897A1 (de) * 2001-02-21 2002-11-07 Novosom Ag Fakultativ kationische Liposomen und Verwendung dieser
US20050156340A1 (en) 2004-01-20 2005-07-21 E Ink Corporation Preparation of capsules
ATE373466T1 (de) * 2001-11-13 2007-10-15 Celator Pharmaceuticals Inc Lipidträgerzusammensetzungen und verfahren zur verbesserten wirkstoffzurückhaltung
US20040082521A1 (en) * 2002-03-29 2004-04-29 Azaya Therapeutics Inc. Novel formulations of digitalis glycosides for treating cell-proliferative and other diseases
KR20050037508A (ko) * 2002-05-24 2005-04-22 와라타 파마수티컬즈, 인크. 당뇨병의 치료
US6998051B2 (en) * 2002-07-03 2006-02-14 Ferro Corporation Particles from supercritical fluid extraction of emulsion
US6966990B2 (en) 2002-10-11 2005-11-22 Ferro Corporation Composite particles and method for preparing
BR0315523A (pt) * 2002-10-22 2005-08-30 Waratah Pharmaceuticals Inc Tratamento de diabetes
US20040229810A1 (en) * 2002-10-22 2004-11-18 Antonio Cruz Gastrin compositions and formulations, and methods of use and preparation
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
HUE025491T2 (en) * 2002-10-29 2016-04-28 Insmed Inc Delayed release of anti-infective agents
US7179484B2 (en) * 2002-11-06 2007-02-20 Azaya Therapeutics, Inc. Protein-stabilized liposomal formulations of pharmaceutical agents
US7083748B2 (en) * 2003-02-07 2006-08-01 Ferro Corporation Method and apparatus for continuous particle production using supercritical fluid
US20060008531A1 (en) * 2003-05-08 2006-01-12 Ferro Corporation Method for producing solid-lipid composite drug particles
US7416756B2 (en) 2003-09-10 2008-08-26 Eastman Chemical Company Process for the recovery of a phytolipid composition
CN1315530C (zh) * 2005-07-04 2007-05-16 重庆大学 蛋白质类药物控制释放系统制备方法
US20070110674A1 (en) * 2005-07-29 2007-05-17 Yuhong Xu Sono-active liposomes and lipid particles and use thereof as contrast agents and active-agent delivery systems
HUE029994T2 (en) 2005-12-08 2017-04-28 Insmed Inc Lipid-based compositions of antiinfectives for treating pulmonary infections
CN101190183B (zh) * 2006-11-29 2010-05-12 上海医药工业研究院 一种盐酸可乐定多泡脂质体及其制备方法
WO2008137717A1 (en) * 2007-05-04 2008-11-13 Transave, Inc. Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US20100102142A1 (en) * 2008-10-28 2010-04-29 Daria Tagliareni Scent dispenser assembly
CN101756902B (zh) * 2008-12-23 2011-10-05 上海医药工业研究院 一种可乐定多囊脂质体及其制备方法
CN104959052B (zh) 2010-04-09 2018-07-13 帕西拉制药有限公司 用于配制大直径合成膜囊泡的方法
EP2394640A1 (en) * 2010-05-21 2011-12-14 MediGene AG Improved liposomal formulations of lipophilic compounds
LT3243526T (lt) 2010-07-06 2020-02-10 Glaxosmithkline Biologicals S.A. Rnr pristatymas, skirtas keleto imuninio atsako paleidimui
BR112013000244A2 (pt) 2010-07-06 2016-05-17 Novartis Ag lipossomas com lipídeos apresentando pka vantajoso para administração de rna
PT2591114T (pt) 2010-07-06 2016-08-02 Glaxosmithkline Biologicals Sa Imunização de mamíferos de grande porte com doses baixas de arn
EP4066857B1 (en) 2010-08-31 2022-12-21 GlaxoSmithKline Biologicals SA Pegylated liposomes for delivery of immunogen-encoding rna
EP3520813B1 (en) 2010-10-11 2023-04-19 GlaxoSmithKline Biologicals S.A. Antigen delivery platforms
ES2770575T3 (es) 2010-10-28 2020-07-02 Pacira Pharmaceuticals Inc Formulación de liberación sostenida de un fármaco antiinflamatorio no esteroideo
JP2014510045A (ja) * 2011-02-08 2014-04-24 ハロザイム インコーポレイテッド ヒアルロナン分解酵素の組成物および脂質製剤ならびに良性前立腺肥大症の治療のためのその使用
JP6320912B2 (ja) * 2011-03-25 2018-05-09 セレクタ バイオサイエンシーズ インコーポレーテッドＳｅｌｅｃｔａ Ｂｉｏｓｃｉｅｎｃｅｓ，Ｉｎｃ． 浸透圧媒介性放出合成ナノ担体
US11896636B2 (en) 2011-07-06 2024-02-13 Glaxosmithkline Biologicals Sa Immunogenic combination compositions and uses thereof
US10722458B2 (en) 2011-12-02 2020-07-28 Pegasus Laboratories, Inc. Amphipathic lipid-based sustained release compositions
WO2013082470A1 (en) * 2011-12-02 2013-06-06 Pegasus Laboratories, Inc. Amphipathic lipid-based sustained release compositions
RU2678433C2 (ru) 2012-05-10 2019-01-29 Пейнреформ Лтд. Депо-составы гидрофобного активного ингредиента и способы их получения
SI2852391T1 (sl) 2012-05-21 2022-04-29 Insmed Incorporated Sistemi za obravnavo pljučnih infekcij
CN102764456B (zh) * 2012-07-24 2014-10-15 上海交通大学 血管栓塞剂及其用途、制备方法
RU2675859C2 (ru) 2012-11-29 2018-12-25 Инсмед Инкорпорейтед Стабилизированные составы ванкомицина
FR3008900B1 (fr) * 2013-07-25 2018-03-30 Centre Nat Rech Scient Nanoparticules lipidiques multicompartimentees
AU2015258947B2 (en) 2014-05-15 2020-04-09 Insmed Incorporated Methods for treating pulmonary non-tuberculous mycobacterial infections
JP6316182B2 (ja) 2014-12-19 2018-04-25 富士フイルム株式会社 リポソームの製造方法及びリポソーム製造装置
EP3372223B1 (en) 2015-11-02 2024-04-17 FUJIFILM Corporation Liposome composition and method for producing same
CN109983013A (zh) 2016-11-18 2019-07-05 帕西拉制药有限公司 美洛昔康锌复合物微粒多囊脂质体制剂及其制备方法
KR102069670B1 (ko) * 2017-03-02 2020-01-23 단디바이오사이언스 주식회사 면역활성물질을 포함하는 다중도메인캡슐, 이의 제조방법, 및 이를 포함하는 면역조절 조성물
CN106924185B (zh) * 2017-03-29 2019-11-26 烟台大学 一种载有囊泡的多囊脂质体的制备方法
EP3773505A4 (en) 2018-03-30 2021-12-22 Insmed Incorporated PROCESS FOR THE CONTINUOUS MANUFACTURING OF LIPOSOMAL MEDICINAL PRODUCTS
CA3098573A1 (en) 2018-05-02 2019-11-07 Insmed Incorporated Methods for the manufacture of liposomal drug formulations
KR102186704B1 (ko) 2019-02-18 2020-12-04 (주)아이엠디팜 서방성 지질 전구 제제 및 이를 포함하는 지질 용액 형태의 서방성 주사용 약학 조성물
US12151024B2 (en) 2021-01-22 2024-11-26 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
CN113509440B (zh) * 2021-03-26 2022-08-30 中国药科大学 一种高包封率酮咯酸多囊脂质体制备及提高其稳定性方法
CN113171343A (zh) * 2021-05-14 2021-07-27 成都大学 一种局部注射用硫酸阿米卡星多囊脂质体及其制备方法
US12285419B2 (en) 2021-10-14 2025-04-29 Pacira Pharmaceuticals, Inc. Bupivacaine multivesicular liposome formulations and uses thereof
CN116983214B (zh) * 2023-07-12 2026-02-03 广州暨大美塑生物科技有限公司 一种化妆品用脂质体及其制备方法和应用
CN117205156A (zh) * 2023-10-26 2023-12-12 徐州医科大学 一种用于干预高原肺水肿的压力敏感的多囊泡脂质体及其制备方法和应用
US12246092B1 (en) 2024-05-20 2025-03-11 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12280149B1 (en) 2024-05-20 2025-04-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12251472B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH588887A5 (fi) * 1974-07-19 1977-06-15 Battelle Memorial Institute
US4897308A (en) * 1975-06-30 1990-01-30 L'oreal Compositions comprising aqueous dispersions of lipid spheres
US4078052A (en) * 1976-06-30 1978-03-07 The United States Of America As Represented By The Secretary Of Health, Education And Welfare Large unilamellar vesicles (LUV) and method of preparing same
US4086257A (en) * 1976-10-12 1978-04-25 Sears Barry D Phosphatidyl quaternary ammonium compounds
CH624011A5 (fi) * 1977-08-05 1981-07-15 Battelle Memorial Institute
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4310506A (en) * 1979-02-22 1982-01-12 California Institute Of Technology Means of preparation and applications of liposomes containing high concentrations of entrapped ionic species
JPS55153713A (en) * 1979-05-02 1980-11-29 Kureha Chem Ind Co Ltd Pharmaceutical preparation of ribosome containing active substance
US4394372A (en) * 1980-12-22 1983-07-19 The Procter & Gamble Company Process for making lipid membrane structures
US4522803A (en) * 1983-02-04 1985-06-11 The Liposome Company, Inc. Stable plurilamellar vesicles, their preparation and use
US4588578A (en) * 1983-08-08 1986-05-13 The Liposome Company, Inc. Lipid vesicles prepared in a monophase
US4599227A (en) * 1983-11-07 1986-07-08 Wisconsin Alumni Research Foundation Injectable pharmaceutical preparation for the induction of multiple follicular growth
JPS60118666A (ja) * 1983-11-30 1985-06-26 太陽誘電株式会社 誘電体磁器組成物
US5077056A (en) * 1984-08-08 1991-12-31 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
IE58981B1 (en) * 1985-10-15 1993-12-15 Vestar Inc Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles
US5204112A (en) * 1986-06-16 1993-04-20 The Liposome Company, Inc. Induction of asymmetry in vesicles
US4781871A (en) * 1986-09-18 1988-11-01 Liposome Technology, Inc. High-concentration liposome processing method
US4752425A (en) * 1986-09-18 1988-06-21 Liposome Technology, Inc. High-encapsulation liposome processing method
US4920016A (en) * 1986-12-24 1990-04-24 Linear Technology, Inc. Liposomes with enhanced circulation time
GB8704171D0 (en) * 1987-02-23 1987-04-01 Clayton Found Res Multivesicular liposomes
JP2666345B2 (ja) * 1987-04-16 1997-10-22 武田薬品工業株式会社 リポソーム製剤およびその製造法
CA1335348C (en) * 1988-03-04 1995-04-25 Yasuaki Ogawa Liposome composition
US5576017A (en) * 1988-05-30 1996-11-19 Depotech Corporation Heterovesicular liposomes
US5422120A (en) * 1988-05-30 1995-06-06 Depotech Corporation Heterovesicular liposomes
BE1001869A3 (fr) * 1988-10-12 1990-04-03 Franz Legros Procede d'encapsulation liposomiale d'antibiotiques aminoglucosidiques, en particulier de la gentamycine.
US5766627A (en) * 1993-11-16 1998-06-16 Depotech Multivescular liposomes with controlled release of encapsulated biologically active substances
RO116341B1 (ro) * 1993-11-16 2001-01-30 Depotech Corp La Jolia Lipozom multivezicular si procedeu de obtinere a acestuia

Also Published As

Publication number Publication date
US5993850A (en) 1999-11-30
KR100387561B1 (ko) 2003-10-08
JPH10502667A (ja) 1998-03-10
BR9508913A (pt) 1997-12-30
WO1996008235A1 (en) 1996-03-21
EP0781123B1 (en) 2006-11-15
CA2199004A1 (en) 1996-03-21
CN1166136A (zh) 1997-11-26
EP0781123A4 (en) 2000-12-20
NZ292830A (en) 1999-04-29
JP3026271B2 (ja) 2000-03-27
NO323581B1 (no) 2007-06-11
NO971149D0 (no) 1997-03-12
CA2199004C (en) 2008-02-19
AU3511595A (en) 1996-03-29
FI119621B (fi) 2009-01-30
EP0781123A1 (en) 1997-07-02
NZ334561A (en) 2000-01-28
FI971037A0 (fi) 1997-03-12
DE69535297T2 (de) 2007-05-16
CN1096850C (zh) 2002-12-25
AU697484B2 (en) 1998-10-08
NO971149L (no) 1997-05-13
MX9701856A (es) 1998-07-31
DE69535297D1 (de) 2006-12-28

Similar Documents

Publication Publication Date Title
FI971037L (fi) Multivesikulääristen liposomien valmistus aktiivisten aineiden vapauttamiseksi kontrolloidusti
FI964253L (fi) Kollageenivalmiste vaikuttavien aineiden säädellyksi vapauttamiseksi
FI973452L (fi) Nauhoitettu annosmuoto aktiivisen aineen pidennettyyn jakamiseen
FI973828L (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
ZA965866B (en) 6-Dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
ZA9610650B (en) 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
AU1740195A (en) Compositions and devices for controlled release of active ingredients
FI963045L (fi) Farmaseuttisesti aktiiviset yhdisteet ja liposomit ja menetelmä niiden käyttämiseksi
FI971776A7 (fi) Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi
TR199501137A2 (tr) Terapötik olarak aktif bilesenler
HUP9802822A3 (en) Halobenzimidazol derivatives, intermediates, preparation thereof and microbocide compositions containing these compounds as active ingredients
FI973320A7 (fi) Kiinteitä aktiiviainetta sisältäviä valmisteita
NO970610D0 (no) Sammensetning for selektiv frigjöring av en aktiv ingrediens
ATE220547T1 (de) Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
NO910874L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
HUP9900365A3 (en) N-aryl-1,2,4-triazolin-5-on derivatives, preparation and use thereof, insecticide, arachnicide and nematocide compositions containing these compounds as active ingredients
IL124841A (en) Pharmaceutical compositions comprising liposomal prostaglandin a method of preparing such compositions and the use of liposomal prostaglandin for said preparation
NO992564D0 (no) Anvendelsen av blandinger av aktive bestanddeler for fremstilling av hypokolesterinemiske midler
IL117943A (en) Dihalopropene compounds and insecticides containing them as active ingredients
DE69518193D1 (de) Präparat mit verzörgerter Wirkstoffabgabe
FI891069A7 (fi) Suun kautta annettava järjestelmä vaikuttavan aineen säädettyä vapautumista varten
NO963871D0 (no) Kombinasjoner av aktive insektisidforbindelser
ATE228575T1 (de) Wirkstoffkombinationen
NO932860D0 (no) Fremgangsmaate for fremstilling av kalsium-l-askorbat-2-fosfat
HRP960254B1 (en) Combinations of active fungicidal agents